Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
5,442 results
  • Pharmacokinetics of a modified, compounded theophylline product in dogs. [Journal Article]
    J Vet Pharmacol Ther 2019Cavett CL, Li Z, … Reinhart JM
  • Theophylline is a commonly used bronchodilator drug for treatment of chronic canine bronchitis, but no formulations validated in dogs are currently available. An oral, modified and compounded theophylline product (MCT), which could fulfil this need, is available through a USP-compliant, veterinary compounding pharmacy; however, its pharmacokinetic properties are unknown. The aim of this study was…
  • Caffeine not associated with irritable behaviour in very low-birth-weight infants. [Journal Article]
    Early Hum Dev 2019; 137:104835Maeda T, Sekiguchi K, … Ihara K
  • This paper is an examination of irritable behaviour in very low-birth-weight infants in relation to caffeine or aminophylline. We assessed tremulous movement (a sub-score of General Movements Optimality Score) in 18 caffeine-treated subjects and 18 aminophylline-treated subjects. Caffeine, unlike aminophylline, was not associated with irritable behaviour at standard dose.
  • StatPearls: Aminophylline [BOOK]
    StatPearls Publishing: Treasure Island (FL) Zafar Gondal Anoosh A Rawal Institute of Health Sciences Zulfiqar Hassam H Rawalpindi Medical University BOOK
  • Aminophylline is a drug combination of theophylline and ethylenediamine in a ratio of 2 to 1. It is FDA approved for relieving symptoms of reversible airway obstruction due to asthma or other chronic lung diseases like chronic bronchitis and emphysema. It is also used to prevent apnea in preterm infants.[1]
New Search Next